A detailed history of Engineers Gate Manager LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 30,244 shares of RNA stock, worth $948,149. This represents 0.03% of its overall portfolio holdings.

Number of Shares
30,244
Holding current value
$948,149
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$37.21 - $48.14 $1.13 Million - $1.46 Million
30,244 New
30,244 $1.39 Million
Q1 2024

May 15, 2024

SELL
$9.16 - $25.52 $241,219 - $672,043
-26,334 Reduced 74.14%
9,186 $234,000
Q4 2023

Feb 14, 2024

BUY
$4.87 - $9.37 $172,982 - $332,822
35,520 New
35,520 $321,000
Q1 2023

May 15, 2023

BUY
$15.35 - $25.65 $268,225 - $448,208
17,474 New
17,474 $268,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.63B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.